Use access key #2 to skip to page content.
$0.71 -0.02 (-2.74%)
8/28/2008 4:00 PM

Generex Biotechnology Corp (GNBT)

CAPS Rating:
***

The Company is engaged primarily in the research, development and commercialization of drug delivery systems and technologies.

View All Commentary (GNBT)

Recs

2

Avatar boyplanner (< 20) Submitted: 12/06/07 2:30 PM : Outperform Start Price: $1.73 GNBT Score: -34.28

Diabetes prevention/care is a billion dollar industry, and depending upon FDA approval, GNBT has unlimited growth potential.

Report this Post Replies: 0 | Reply

Featured Broker Partners